pubmed-article:17936889 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17936889 | lifeskim:mentions | umls-concept:C0220806 | lld:lifeskim |
pubmed-article:17936889 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
pubmed-article:17936889 | lifeskim:mentions | umls-concept:C0214743 | lld:lifeskim |
pubmed-article:17936889 | lifeskim:mentions | umls-concept:C0458827 | lld:lifeskim |
pubmed-article:17936889 | lifeskim:mentions | umls-concept:C1099354 | lld:lifeskim |
pubmed-article:17936889 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:17936889 | lifeskim:mentions | umls-concept:C1527148 | lld:lifeskim |
pubmed-article:17936889 | lifeskim:mentions | umls-concept:C0205349 | lld:lifeskim |
pubmed-article:17936889 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:17936889 | pubmed:dateCreated | 2008-1-21 | lld:pubmed |
pubmed-article:17936889 | pubmed:abstractText | RNA interference is an endogenous cellular mechanism in which short interfering RNAs (siRNAs) direct the sequence specific degradation of a target mRNA. siRNAs can be synthesized with chemical modifications to increase stability and reduce double-stranded RNA-induced immune responses without affecting their ability to elicit degradation of target mRNA. | lld:pubmed |
pubmed-article:17936889 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17936889 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17936889 | pubmed:language | eng | lld:pubmed |
pubmed-article:17936889 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17936889 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:17936889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17936889 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17936889 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17936889 | pubmed:month | Jan | lld:pubmed |
pubmed-article:17936889 | pubmed:issn | 1097-6825 | lld:pubmed |
pubmed-article:17936889 | pubmed:author | pubmed-author:GelfandErwin... | lld:pubmed |
pubmed-article:17936889 | pubmed:author | pubmed-author:PoliskyBarryB | lld:pubmed |
pubmed-article:17936889 | pubmed:author | pubmed-author:TakedaKatsuyu... | lld:pubmed |
pubmed-article:17936889 | pubmed:author | pubmed-author:BalhornAnnett... | lld:pubmed |
pubmed-article:17936889 | pubmed:author | pubmed-author:KossenKarlK | lld:pubmed |
pubmed-article:17936889 | pubmed:author | pubmed-author:KoyaToshiyuki... | lld:pubmed |
pubmed-article:17936889 | pubmed:author | pubmed-author:RichardsIvan... | lld:pubmed |
pubmed-article:17936889 | pubmed:author | pubmed-author:LucasJoseph... | lld:pubmed |
pubmed-article:17936889 | pubmed:author | pubmed-author:LivelyTricia... | lld:pubmed |
pubmed-article:17936889 | pubmed:author | pubmed-author:ZinnenShawnS | lld:pubmed |
pubmed-article:17936889 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:17936889 | pubmed:volume | 121 | lld:pubmed |
pubmed-article:17936889 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17936889 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17936889 | pubmed:pagination | 88-94 | lld:pubmed |
pubmed-article:17936889 | pubmed:meshHeading | pubmed-meshheading:17936889... | lld:pubmed |
pubmed-article:17936889 | pubmed:meshHeading | pubmed-meshheading:17936889... | lld:pubmed |
pubmed-article:17936889 | pubmed:meshHeading | pubmed-meshheading:17936889... | lld:pubmed |
pubmed-article:17936889 | pubmed:meshHeading | pubmed-meshheading:17936889... | lld:pubmed |
pubmed-article:17936889 | pubmed:meshHeading | pubmed-meshheading:17936889... | lld:pubmed |
pubmed-article:17936889 | pubmed:meshHeading | pubmed-meshheading:17936889... | lld:pubmed |
pubmed-article:17936889 | pubmed:meshHeading | pubmed-meshheading:17936889... | lld:pubmed |
pubmed-article:17936889 | pubmed:meshHeading | pubmed-meshheading:17936889... | lld:pubmed |
pubmed-article:17936889 | pubmed:meshHeading | pubmed-meshheading:17936889... | lld:pubmed |
pubmed-article:17936889 | pubmed:meshHeading | pubmed-meshheading:17936889... | lld:pubmed |
pubmed-article:17936889 | pubmed:meshHeading | pubmed-meshheading:17936889... | lld:pubmed |
pubmed-article:17936889 | pubmed:meshHeading | pubmed-meshheading:17936889... | lld:pubmed |
pubmed-article:17936889 | pubmed:meshHeading | pubmed-meshheading:17936889... | lld:pubmed |
pubmed-article:17936889 | pubmed:meshHeading | pubmed-meshheading:17936889... | lld:pubmed |
pubmed-article:17936889 | pubmed:meshHeading | pubmed-meshheading:17936889... | lld:pubmed |
pubmed-article:17936889 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:17936889 | pubmed:articleTitle | Effect of chemically modified IL-13 short interfering RNA on development of airway hyperresponsiveness in mice. | lld:pubmed |
pubmed-article:17936889 | pubmed:affiliation | Division of Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206, USA. | lld:pubmed |
pubmed-article:17936889 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:17936889 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
pubmed-article:17936889 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |